Residual cancer burden has been identified as correlative to long-term clinical outcomes following NAC in breast cancer patients, and increased Ki-67 in the interim between finishing NAC and undergoing resection indicates poorer outcomes [89,90,91]. The gene discussed is MKI67; the disease is breast cancer.